# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-326136
Filing Date
2026-07-30
Accepted
2026-07-30 16:13:09
Documents
92
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | flgt-20260630.htm iXBRL | 10-Q | 4204442
2 | EX-31.1 | flgt-ex31_1.htm | EX-31.1 | 16517
3 | EX-31.2 | flgt-ex31_2.htm | EX-31.2 | 16651
4 | EX-32.1 | flgt-ex32_1.htm | EX-32.1 | 19201
| Complete submission text file | 0001193125-26-326136.txt |  | 17883316

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | flgt-20260630.xsd | EX-101.SCH | 1605901
96 | EXTRACTED XBRL INSTANCE DOCUMENT | flgt-20260630_htm.xml | XML | 4507932

Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 261223450
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)